Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation (Q44630730)
Jump to navigation
Jump to search
scientific article published in November 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation |
scientific article published in November 2003 |
Statements
1 reference
Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation (English)
1 reference
1 reference
1 reference
1 reference
Maurillo L
1 reference
Del Poeta G
1 reference
Mazzone C
1 reference
Tamburini A
1 reference
Del Principe MI
1 reference
Consalvo MI
1 reference
Cudillo L
1 reference
Picardi A
1 reference
Franchi A
1 reference
Lo-Coco F
1 reference
Amadori S
1 reference
1 November 2003
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference